Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:ENFN

Enfusion (ENFN) Stock Price, News & Analysis

Enfusion logo

About Enfusion Stock (NYSE:ENFN)

Advanced Chart

Key Stats

Today's Range
$10.74
$10.87
50-Day Range
$10.85
$10.85
52-Week Range
$7.83
$11.80
Volume
2.46 million shs
Average Volume
735,304 shs
Market Capitalization
$1.40 billion
P/E Ratio
271.29
Dividend Yield
N/A
Price Target
$12.25
Consensus Rating
Hold

Company Overview

Receive ENFN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enfusion and its competitors with MarketBeat's FREE daily newsletter.

ENFN Stock News Headlines

Clearwater Analytics reinstated with an Overweight at JPMorgan
The Coin That Could Define Trump’s Crypto Presidency
When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”
Clearwater Analytics Finalizes Acquisition of Enfusion
See More Headlines

ENFN Stock Analysis - Frequently Asked Questions

Enfusion, Inc. (NYSE:ENFN) released its quarterly earnings data on Monday, March, 3rd. The company reported $0.01 earnings per share for the quarter, missing the consensus estimate of $0.03 by $0.02. The company earned $52.94 million during the quarter, compared to the consensus estimate of $53.98 million. Enfusion had a net margin of 1.70% and a trailing twelve-month return on equity of 6.67%.

Enfusion (ENFN) raised $300 million in an initial public offering (IPO) on Thursday, October 21st 2021. The company issued 18,750,000 shares at a price of $15.00-$17.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that Enfusion investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Alphabet (GOOG).

Company Calendar

Last Earnings
3/03/2025
Today
8/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Prepackaged software
Sub-Industry
Computer Software
Current Symbol
NYSE:ENFN
CIK
1868912
Fax
N/A
Employees
890
Year Founded
1997

Price Target and Rating

High Price Target
$13.00
Low Price Target
$11.50
Potential Upside/Downside
+12.9%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.03
Trailing P/E Ratio
271.29
Forward P/E Ratio
180.82
P/E Growth
1.85
Net Income
$6.03 million
Net Margins
1.70%
Pretax Margin
3.64%
Return on Equity
6.67%
Return on Assets
4.86%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.62
Quick Ratio
3.62

Sales & Book Value

Annual Sales
$201.61 million
Price / Sales
6.94
Cash Flow
$0.14 per share
Price / Cash Flow
78.75
Book Value
$0.61 per share
Price / Book
17.79

Miscellaneous

Outstanding Shares
129,001,000
Free Float
81,720,000
Market Cap
$1.40 billion
Optionable
Optionable
Beta
0.92

Social Links

10 Stocks Set to Soar in Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NYSE:ENFN) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners